Staccato loxapine: Phase IIb start

In 1Q09, Alexza plans to start a Phase IIb trial of inhaled AZ-104. In 2006, Alexza out-licensed AZ-104 to Symphony Allegro, which was formed by equity firm Symphony Capital (see BioCentury, Dec. 11, ...